A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Public ClinicalTrials.gov record NCT07085104. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Study Evaluating the Safety and Preliminary Efficacy of ALLO-329, a Dual Anti-CD19/Anti-CD70 Allogeneic CAR T Cell Product in Autoimmune Disease
Study identification
- NCT ID
- NCT07085104
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Allogene Therapeutics
- Industry
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Interventions
- ALLO-329 Genetic
- Cyclophosphamide Drug
Genetic · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 69 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2025
- Primary completion
- Jan 31, 2028
- Completion
- Sep 30, 2032
- Last update posted
- Apr 6, 2026
2025 – 2032
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Phoenix | Arizona | 85054 | Recruiting |
| University of Colorado Denver | Aurora | Colorado | 80045 | Recruiting |
| Mayo Clinic | Jacksonville | Florida | 32224 | Recruiting |
| The University of Chicago Medical Center | Chicago | Illinois | 60637 | Recruiting |
| University of Iowa | Iowa City | Iowa | 52242 | Recruiting |
| Norton Cancer Institute, St. Matthews Campus | Louisville | Kentucky | 40207 | Recruiting |
| Astera Cancer Care | East Brunswick | New Jersey | 08816 | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Recruiting |
| Duke University Medical Center | Durham | North Carolina | 27710 | Recruiting |
| Medical University of South Carolina | Charleston | South Carolina | 29605 | Recruiting |
| Prisma Health | Greenville | South Carolina | 29425 | Recruiting |
| LDS Hospital - lntermountain Health | Salt Lake City | Utah | 84143 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07085104, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2026 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07085104 live on ClinicalTrials.gov.